Cibc Private Wealth Group, LLC Collegium Pharmaceutical, Inc Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 249 shares of COLL stock, worth $7,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249
Previous 249
-0.0%
Holding current value
$7,768
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$181 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$73.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51.7 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...